Monitoring

Everything here about regular checks, blood tests, calprotectin and keeping track of the condition: our articles first, then short answers, the words you may hear, and the original sources.

Articles

Common questions 14

What is a faecal calprotectin test?

It is a test on a small sample of poo that measures calprotectin, a protein released by white blood cells when the gut is inflamed. NICE recommends it to help doctors tell IBD apart from IBS. A high result suggests inflammation that needs looking into, but infections and some other conditions can raise it too. It is also used to monitor Crohn's once diagnosed.

Sources

What blood tests are used for Crohn's?

NICE's guidance for GPs suggests a full blood count (to look for anaemia and other signs), inflammation markers such as CRP and ESR, kidney and liver tests including albumin, iron, B12, folate and vitamin D levels, and a coeliac test to rule that out. Crohn's & Colitis UK explains that CRP rises with inflammation but can be normal even when the gut is inflamed, so blood tests are used alongside other tests rather than on their own.

Sources

What is an MRI enterography (small bowel MRI)?

It is an MRI scan focused on the small bowel. Hospital leaflets explain that you fast, then drink a special liquid over about an hour to fill the bowel, and may have injections to steady the bowel and highlight it. The scan uses no radiation. A UK trial found it very good at detecting small bowel Crohn's, and MRI is usually preferred to CT for repeated checks.

Sources

Can an ultrasound scan show Crohn's?

Yes. Bowel (intestinal) ultrasound uses sound waves rather than radiation. A UK trial found it good at detecting small bowel Crohn's, although MRI was more accurate at showing how much bowel was affected. Reviews say ultrasound is quick, inexpensive and useful for checking response to treatment. The IBD Standards ask services to prioritise MRI and ultrasound over CT where appropriate.

Sources

What is the Harvey-Bradshaw Index (HBI)?

It is a short score doctors use to measure how active Crohn's is, based on how you were yesterday: general wellbeing, tummy pain, number of loose poos, any lump in the tummy, and points for complications such as joint, eye, skin or bottom problems. A patient guide shows how to fill it in. Clinician calculators describe a score under 5 as remission and higher scores as mild, moderate or severe activity.

Sources

What is the CDAI, and how is it different from the HBI?

The Crohn's Disease Activity Index (CDAI) is an older, longer score. It needs a 7-day symptom diary, your weight and a blood test result, so it takes more effort to work out. A CDAI under 150 is taken as a marker of remission and over 450 as a marker of severe Crohn's. The Harvey-Bradshaw Index is a simpler score based on just the previous day's symptoms and does not need a blood test.

Sources

Why do I still need tests when I feel well?

Symptoms do not always match what is happening inside. Crohn's & Colitis UK says calprotectin can be raised even without symptoms, and tests check for anaemia and medicine side effects. Some teams use a 'treat to target' approach, aiming for healing of the gut lining and normal markers rather than just fewer symptoms. Monitoring may include blood and poo tests, scans, colonoscopy and, in some hospitals, home calprotectin kits.

Sources

Does Crohn's increase my risk of bowel cancer, and will I need regular colonoscopies?

It depends where your Crohn's is. Crohn's & Colitis UK says Crohn's affecting the colon raises bowel cancer risk, starting about eight years after symptoms begin, while Crohn's that does not affect the colon does not. Having PSC, a liver condition, raises it further. The overall risk is low. People at higher risk should be offered a surveillance colonoscopy, usually every 1 to 3 years. NICE and the British Society of Gastroenterology set out who needs one.

Sources

What does 'treat to target' mean?

It means your team agrees goals in advance and adjusts treatment until you reach them, rather than waiting for symptoms. The STRIDE-II expert agreement says early goals are feeling better and getting blood and poo inflammation tests back to normal; longer-term goals are a healed bowel lining, no disability, good quality of life and normal growth in children. The CALM trial found that stepping up treatment when tests showed inflammation, not just when symptoms flared, led to more bowel healing.

Sources

What is PSC and why is it linked to Crohn's?

Primary sclerosing cholangitis (PSC) is a rare condition where the bile ducts become inflamed and scarred, which can eventually damage the liver. Crohn's & Colitis UK says it affects around 1 in 50 people with IBD and can cause tiredness, itching, weight loss and jaundice. Liver UK notes people with PSC and IBD are usually offered regular colonoscopies.

Sources

Why do I need a TPMT blood test before azathioprine or mercaptopurine?

TPMT is an enzyme that helps the body break down azathioprine and mercaptopurine. People with low or no TPMT activity can have serious side effects on the bone marrow. NICE says TPMT should be checked before these medicines are offered, and that they should not be given if activity is deficient. Crohn's & Colitis UK explains your team may adjust your treatment or choose a different medicine based on the result. A recent blood transfusion can affect the result.

Sources

Why do I need so many blood tests on azathioprine?

Azathioprine and mercaptopurine can affect the bone marrow, which makes blood cells, and the liver. The NHS and Crohn's & Colitis UK say you need regular blood tests for as long as you take them. Tests are usually frequent when you start and less often once things are stable, but the schedule varies between hospitals. NICE says to keep watching blood counts even if your TPMT result was normal.

Sources

Why does my team check drug levels and antibodies on infliximab or adalimumab?

Some people's bodies make antibodies against infliximab or adalimumab, which can stop the medicine working. Crohn's & Colitis UK says your team may check the level of medicine and antibodies in your blood. The 2025 BSG guideline says these tests can help decide whether to adjust treatment or switch to a different medicine, and NHS Lothian describes checking levels after starting and then at least yearly. Taking an immunomodulator alongside can lower the chance of antibodies.

Sources

Can Crohn's come back after surgery, and how is that prevented?

Yes. Crohn's & Colitis UK says Crohn's may return after surgery; doctors often check the area around the bowel join with a colonoscopy. NICE suggests azathioprine, often with up to three months of metronidazole, after a complete ileocolonic resection. The POCER trial and a Cochrane review support checking with a colonoscopy after surgery and stepping up treatment if needed. The 2025 BSG guideline suggests offering early advanced treatment, especially to people at higher risk, such as smokers.

Sources

Words you might hear 26

Anti-drug antibodies
Antibodies your immune system can make against a biologic, which may stop it working.
Biomarker
Something measurable in the body, such as a blood or poo test result, that gives information about disease or how it might behave. CRP and faecal calprotectin are examples.
C-reactive protein
A blood test for a protein made by the liver that rises when there is inflammation somewhere in the body. It can be normal even when Crohn's is active.
Colonoscopy
A test where a thin, flexible camera tube is passed through the bottom to look at the whole large bowel, and sometimes the end of the small bowel, and to take biopsies.
Crohn's disease activity index
A longer score of Crohn's activity using a 7-day symptom diary, weight and a blood test, mainly used in drug trials. Under 150 usually means remission.
Deep remission
Being in both clinical remission (no symptoms) and endoscopic remission (healed lining) at the same time.
Endoscopic remission
When a camera test (colonoscopy or similar) shows the bowel lining no longer has active inflammation or ulcers.
Faecal calprotectin
A poo test measuring a protein released when the gut is inflamed. It helps tell IBD apart from IBS and is used to check on Crohn's once diagnosed.
Ferritin
A blood test that reflects how much iron is stored in your body. Inflammation can make it look higher than it really is.
Full blood count
A routine blood test counting red cells, white cells and platelets. It can show anaemia, infection or inflammation, and checks for side effects of some Crohn's medicines.
Gastroenterologist
A hospital doctor who specialises in the digestive system and usually leads the IBD team.
Harvey-bradshaw index
A quick score of how active Crohn's is, based on the previous day's wellbeing, tummy pain, loose poos, any tummy lump and complications. Under 5 usually means remission.
Ibd nurse specialist
A nurse with specialist training in IBD who is often your main contact, runs the advice line and helps manage flares.
Intestinal ultrasound
An ultrasound scan of the bowel using a probe on the tummy and sound waves. It uses no radiation and can show thickened, inflamed bowel and complications.
Mri enterography
An MRI scan of the small bowel after drinking a special liquid to fill it. It uses no radiation and shows inflammation and complications in parts of the gut a colonoscopy cannot reach.
Mucosal healing
When the gut lining looks healed on a camera test, not just when symptoms have settled. Many IBD teams now aim for this as a treatment goal.
Multidisciplinary team
The group of professionals who look after people with IBD together, such as gastroenterologists, IBD nurses, surgeons, dietitians, pharmacists and psychologists.
Post-operative recurrence
When Crohn's comes back after an operation, usually near the bowel join.
Primary sclerosing cholangitis
A long-term liver condition where the bile ducts become inflamed and scarred. In people with Crohn's or colitis it greatly raises the risk of bowel cancer.
Remission
A period when Crohn's is under control: you feel better and tests show less inflammation. It does not mean cured.
Surveillance colonoscopy
A regular camera check of the large bowel to look for early changes that could turn into cancer, offered to people with Crohn's affecting the colon who are at higher risk.
Therapeutic drug monitoring
Blood tests that measure how much of a medicine (such as infliximab or adalimumab) is in your blood, and whether your body has made antibodies against it, so the dose can be adjusted.
Thiopurine metabolites
Breakdown products of azathioprine measured in the blood to check the medicine is at a safe and useful level.
TPMT
An enzyme that helps break down azathioprine and mercaptopurine. A blood test checks it before you start, because low levels raise the risk of serious side effects.
Transmural healing
Healing through the whole thickness of the bowel wall, usually checked by a scan such as MRI or bowel ultrasound. A deeper level of healing than the lining alone.
Treat to target
An approach where treatment is adjusted until measured goals are met, such as normal calprotectin or a healed gut lining, rather than only until symptoms improve.

Further reading 47

The original NHS, NICE, charity and research pages on this topic, with our summary of each.

Guides for patients and families

Web pages 7

MRI scan

NHS Web page Sep 2025 For patients

The NHS page on MRI scans, which take detailed pictures of the inside of the body and are used to diagnose conditions and check how treatment is working. It covers preparation, especially removing anything metal, the safety questions you will be asked, and what lying in the scanner is like. It is a general page; MRI of the small bowel for Crohn's (MRI enterography) is covered by hospital leaflets.

Topics Diagnosis and tests Monitoring

Jargon explained MRI enterography contrast

Ultrasound scan

NHS Web page Feb 2025 For patients

A general guide to ultrasound scans, which use sound waves to show images of organs and other structures. It explains why scans are done, including to monitor a condition, and the simple preparation sometimes needed. Bowel ultrasound for Crohn's uses the same technique.

Topics Diagnosis and tests Monitoring

Jargon explained intestinal ultrasound

Colonoscopy

NHS Web page Apr 2024 For patients

Explains what a colonoscopy is (a thin tube with a camera passed into the bowel), why you might be sent for one, including checking for Crohn's, and how to get ready. It describes taking laxatives beforehand to empty the bowel, what happens on the day and what to expect afterwards. It notes that most of the time the test does not find anything worrying.

Topics Diagnosis and tests Monitoring Cancer risk and screening

Jargon explained colonoscopy bowel preparation biopsy polyp

Blood tests

NHS Web page Nov 2023 For patients

A general NHS guide to blood tests: why they are done, how to book one and what having blood taken involves. It explains that blood tests can help find the cause of symptoms and show how well a condition is being managed, which is how they are used in Crohn's.

Topics Diagnosis and tests Monitoring

Jargon explained full blood count C-reactive protein

Primary sclerosing cholangitis (PSC) in adults

Liver UK (formerly British Liver Trust) Web page For patients

Explains PSC, a rare long-term condition where bile ducts in and around the liver become scarred and narrowed. It often causes no symptoms for years; later signs can include tiredness, itching and yellowing of the skin. The charity notes it often occurs alongside IBD and that people with both are usually offered regular colonoscopy checks. The page states it was last reviewed in 2019.

Topics Beyond the gut Complications Monitoring

Jargon explained primary sclerosing cholangitis bile duct jaundice cholangiogram

Leaflets 7

IBD home monitoring patient information

University Hospitals Birmingham NHS Foundation Trust Leaflet Oct 2024 For patients

Describes a hospital home monitoring service where eligible people with Crohn's or UC share symptoms and test results with their IBD team online, including results from a home calprotectin test kit. The team uses the information to set check-ups based on need, and it does not replace the IBD helpline.

Topics Monitoring

Jargon explained faecal calprotectin home monitoring

Inflammatory bowel disease service: information for patients

University Hospital Southampton NHS Foundation Trust Leaflet Oct 2024 For patients

A hospital IBD service leaflet showing how a typical IBD team works: how the advice line handles flare-ups and medicine problems, and the routine blood, poo and other tests used to keep an eye on the condition, including faecal calprotectin. It gives a good picture of what ongoing IBD care looks like.

Topics Monitoring Flare-ups

Jargon explained IBD nurse specialist faecal calprotectin advice line

How to complete your own Harvey-Bradshaw Index: a guide for patients with Crohn's disease

New Zealand Society of Gastroenterology Leaflet For patients

A patient leaflet that walks through scoring your own Harvey-Bradshaw Index based on how you were yesterday: general wellbeing, tummy pain, number of loose poos, any lump in the tummy, and points for complications such as joint, eye, mouth, skin or bottom problems. The points are added up for a total score to share with your IBD team.

Topics Monitoring Flare-ups

Jargon explained Harvey-Bradshaw Index abdominal mass fistula uveitis erythema nodosum

Faecal Calprotectin Test

Northern Lincolnshire and Goole NHS Foundation Trust Leaflet Dec 2025 For patients

A hospital leaflet explaining the calprotectin poo test, which shows whether there is inflammation in the gut and is used both to help diagnose and to monitor conditions such as IBD. It explains how to collect the sample and warns that anti-inflammatory painkillers such as ibuprofen can affect the result, so ask your doctor before stopping or continuing them.

Topics Diagnosis and tests Monitoring

Jargon explained faecal calprotectin NSAIDs

Having a small bowel MRI

King's College Hospital NHS Foundation Trust Leaflet 2025 For patients

A hospital leaflet on what happens at a small bowel MRI (MRI enterography). You fast beforehand, drink a mannitol mixture over about an hour to fill the bowel, and may have injections: one to calm bowel movements so pictures are not blurred and a contrast dye to highlight the bowel. The scan itself takes around 30 minutes; the drink can cause diarrhoea afterwards.

Topics Diagnosis and tests Monitoring

Jargon explained MRI enterography contrast Buscopan gadolinium

Inflammatory Bowel Disease (IBD) telephone advice line service

Cambridge University Hospitals NHS Foundation Trust Leaflet For patients

An example of how a hospital IBD advice line works: a non-urgent, voicemail-first service for treatment questions and flares between clinic appointments. It is explicit that more urgent problems should go to an out-of-hours GP or NHS 111, and clinical emergencies to A&E.

Topics Flare-ups Urgent help Monitoring

Jargon explained ibd advice line ibd nurse specialist

Guides 5

Tests and investigations

Crohn's & Colitis UK Guide Dec 2025 For patients

A detailed guide to the tests used to diagnose and monitor Crohn's and colitis: blood tests (full blood count, CRP, liver and kidney tests), poo tests including faecal calprotectin and FIT, endoscopies with tips on bowel prep, capsule endoscopy and the dummy patency capsule, and X-rays, CT, MRI and ultrasound. It explains what results can and cannot tell you, for example that calprotectin can be normal during a flare in the small bowel.

Topics Diagnosis and tests Monitoring

Jargon explained full blood count C-reactive protein faecal calprotectin faecal immunochemical test colonoscopy gastroscopy capsule endoscopy patency capsule biopsy bowel preparation

Risk of bowel cancer and other gut-related cancers

Crohn's & Colitis UK Guide May 2025 For patients

Explains which people with Crohn's or Colitis have a raised risk of bowel and other gut cancers. Crohn's affecting the colon raises bowel cancer risk, starting about eight years after symptoms begin, and having PSC raises it further, while Crohn's that does not affect the colon does not. People at higher risk should be offered surveillance colonoscopy, usually every 1 to 3 years depending on risk. It also covers symptoms to watch for and ways to lower your risk.

Topics Cancer risk and screening Monitoring

Jargon explained surveillance colonoscopy primary sclerosing cholangitis dysplasia colorectal cancer

Infliximab

Crohn's & Colitis UK Guide Jun 2024 For patients

A guide to infliximab, an anti-TNF biologic given by drip or as an injection under the skin. It lists the original brand Remicade and biosimilars such as Remsima, Inflectra, Flixabi and Zessly, and explains checks before starting, that your team may measure drug and antibody levels in your blood, and possible side effects.

Topics Biologics and newer medicines Monitoring

Jargon explained anti-TNF infusion subcutaneous biosimilar drug levels antibodies

Guidelines 2

IBD Standards 2026

IBD UK Guideline 2026 Patients and professionals

The UK-wide standards for IBD care from the IBD UK alliance, updated in 2026 with 60 statements built on the experiences of about 26,000 patients. The pre-diagnosis section calls for local referral pathways using calprotectin and/or FIT, a specialist appointment or straight-to-test within four weeks of referral, and endoscopy and scans within 6 weeks for routine care and 2 weeks if urgent, favouring MRI and ultrasound because they avoid radiation. A patient version is available.

Topics Diagnosis and tests Monitoring Living well Research

Jargon explained faecal calprotectin faecal immunochemical test referral MRI enterography intestinal ultrasound IBD Standards multidisciplinary team

Inflammatory bowel disease (QS81)

NICE Guideline Feb 2015 Patients and professionals

NICE's quality standard for diagnosing and managing Crohn's and ulcerative colitis. Its four statements say people with suspected IBD should get a specialist assessment within 4 weeks of referral, have support from a multidisciplinary team, have surgery done by a colorectal surgeon from the IBD team, and be monitored for side effects of their medicines.

Topics Diagnosis and tests Monitoring

Jargon explained inflammatory bowel disease multidisciplinary team referral

Systematic reviews 1

Colonoscopy-guided therapy for the prevention of post-operative recurrence of Crohn's disease

Cochrane (via PMC) Systematic review Aug 2020 Patients and professionals

A Cochrane review suggesting that stepping up treatment based on a colonoscopy after surgery may reduce Crohn's coming back compared with waiting for symptoms. Whether to start treatment immediately after surgery or only after a colonoscopy remains uncertain.

Topics Surgery Monitoring Research

Jargon explained post-operative recurrence colonoscopy prophylaxis

Studys 1

Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial

The Lancet Study Dec 2017 Patients and professionals

CALM compared deciding treatment on symptoms alone with 'tight control', where treatment was stepped up if blood or poo tests (CRP and faecal calprotectin) showed inflammation even when people felt fine. After 48 weeks, 46% in the tight control group had a healed bowel lining compared with 30% in the symptom-only group. It is a cornerstone of the 'treat to target' approach.

Topics Monitoring Biologics and newer medicines Research

Jargon explained tight control faecal calprotectin CRP mucosal healing treat to target

Data 1

National IBD Registry

National IBD Registry Data Patients and professionals

The UK registry that collects health data from people with IBD to help improve care and support research. It has been running since 2012 and joined NHS England in 2026. Hospital teams use it to compare their services, and people with IBD can find out what data is collected about them.

Topics Research Monitoring

Jargon explained registry quality improvement

For health professionals

Guidelines 12

British Society of Gastroenterology guidelines on colorectal surveillance in inflammatory bowel disease

Gut (BMJ) via PubMed Central Guideline Apr 2025 For professionals

The 2025 UK guideline on regular colonoscopy checks for bowel cancer in adults with IBD affecting the colon, updating the 2010 version. It notes that people with IBD still have a higher bowel cancer risk than the general population and makes 73 statements on how a surveillance service should be run.

Topics Monitoring Cancer risk and screening

Jargon explained surveillance colonoscopy colorectal cancer

Colorectal cancer prevention: colonoscopic surveillance in adults with ulcerative colitis, Crohn's disease or adenomas (CG118)

NICE Guideline Sep 2022 For professionals

NICE's guideline on using regular colonoscopies to look for early signs of bowel cancer in adults with ulcerative colitis or Crohn's affecting the colon, and in people with polyps. Its aim is to find bowel cancer early in the people most at risk.

Topics Monitoring Cancer risk and screening

Jargon explained colonoscopy surveillance colonoscopy polyp adenoma colorectal cancer

STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD)

Gastroenterology Guideline Apr 2021 For professionals

An international expert agreement on what 'treat to target' should aim for in IBD. Short-term goals are feeling better and getting blood and poo inflammation tests back to normal. Long-term goals include a healed bowel lining seen at endoscopy, no disability, a normal quality of life, and normal growth in children. Healing through the full bowel wall in Crohn's is not yet a formal target but is a sign of deeper remission.

Topics Monitoring Research Medicines

Jargon explained treat to target endoscopic healing transmural healing biomarker calprotectin CRP clinical remission

Therapeutic monitoring of TNF-alpha inhibitors in Crohn's disease (HTG401, formerly DG22)

NICE Guideline Feb 2016 For professionals

NICE guidance on laboratory test kits that measure how much infliximab or adalimumab is in the blood and whether the body has made antibodies against the drug. The guidance was first published as diagnostics guidance 22 and has been moved into NICE's HealthTech programme without changing its content.

Topics Monitoring Biologics and newer medicines

Jargon explained therapeutic drug monitoring drug level anti-drug antibodies ELISA anti-TNF

ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 1

European Crohn's and Colitis Organisation (J Crohns Colitis) Guideline Jul 2025 For professionals

A joint European guideline from gut doctors, radiologists, pathologists and bowel ultrasound experts on which tests to use to diagnose IBD, spot complications and keep track of it over time. It also covers testing in special situations such as pregnancy, after surgery and bowel cancer screening.

Topics Diagnosis and tests Monitoring Cancer risk and screening

Jargon explained intestinal ultrasound MRI enterography histology surveillance colonoscopy

British Society of Gastroenterology guidelines on colorectal surveillance in inflammatory bowel disease

British Society of Gastroenterology Guideline 2025 For professionals

The 2025 update of UK guidance on bowel cancer surveillance for people over 16 with IBD affecting the colon. It says people with IBD still have a higher risk of bowel cancer than the general population despite better treatment, and sets out who should and should not have surveillance, when to start and stop, and the importance of shared decision-making with patients.

Topics Cancer risk and screening Monitoring

Jargon explained surveillance colonoscopy dysplasia colorectal cancer

British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults

Gut (BMJ) via PubMed Central Guideline Sep 2019 For professionals

The free full text of the 2019 BSG guideline, written with surgeons, specialist nurses, dietitians, radiologists, GPs and Crohn's & Colitis UK. It reviewed a very large body of research to make recommendations for adults with IBD. It has been replaced by the 2025 guideline but is a freely readable reference on diagnosis and assessment.

Topics About Crohn's disease Diagnosis and tests Monitoring Research Medicines Surgery

Jargon explained inflammatory bowel disease consensus guideline IBD

Management of pediatric Crohn's disease: an ECCO-ESPGHAN guideline update

ECCO and ESPGHAN (J Crohns Colitis) Guideline Aug 2026 For professionals

The newest European guideline for children with Crohn's, agreed by 27 experts. Children at high risk of a difficult course should start an anti-TNF biologic first, with blood-level checks of the drug. For lower-risk children, a liquid-only diet (EEN) or the Crohn's Disease Exclusion Diet with partial liquid feeds are the preferred first treatments. Long-term goals include a healed bowel lining, normal growth and a good quality of life.

Topics Children and young people Diet and nutrition Biologics and newer medicines Monitoring

Jargon explained anti-TNF therapeutic drug monitoring exclusive enteral nutrition endoscopic remission

British Society of Gastroenterology guidelines on inflammatory bowel disease in adults: 2025

British Society of Gastroenterology Guideline Jun 2025 For professionals

The current UK specialist guideline for managing IBD in adults, replacing the 2019 version. It is designed to sit alongside the IBD Standards and encourage use of the national primary care pathway for lower gut symptoms so diagnosis is quicker and more accurate. Among its general principles, it recommends classifying Crohn's using the Montreal system.

Topics About Crohn's disease Diagnosis and tests Medicines Monitoring Complications Surgery

Jargon explained Montreal classification remission endoscopic remission inflammatory bowel disease advanced therapy GRADE induction maintenance

British Society of Gastroenterology guidelines on inflammatory bowel disease in adults: 2025

British Society of Gastroenterology (Gut) Guideline Jun 2025 For professionals

The 2025 update of the UK specialist guideline for adults with Crohn's or colitis, replacing the 2019 version. It is designed to sit alongside the IBD UK Standards and to encourage GPs to use the national referral pathway for bowel symptoms, so people get diagnosed sooner and more accurately. It was written without drug-company funding and is aimed mainly at the UK, though it can be used elsewhere.

Topics Research Medicines Diagnosis and tests Monitoring

Jargon explained guideline primary care diagnostic pathway

Crohn's disease: management (NG129)

NICE Guideline May 2019 For professionals

NICE's guideline for the NHS in England on managing Crohn's in children, young people and adults. It covers giving people information and support, treatment to bring Crohn's under control and keep it there, surgery, keeping remission after surgery, checking bone health, and pregnancy. It is about care after diagnosis rather than how Crohn's is diagnosed.

Topics About Crohn's disease Medicines Surgery Monitoring Pregnancy and fertility Children and young people Steroids Immunosuppressants

Jargon explained remission inducing remission maintaining remission osteopenia NICE guideline induce remission maintain remission glucocorticosteroid thiopurine TPMT resection stricture

Systematic reviews 3

Outcomes and Strategies to Support a Treat-to-target Approach in Inflammatory Bowel Disease: A Systematic Review

Journal of Crohn's and Colitis via PubMed Central Systematic review Feb 2020 For professionals

Reviews the evidence for 'treat to target', where treatment is adjusted not just to symptoms but to measured goals such as a healed bowel lining and normal blood or poo markers. It explains the idea behind the STRIDE targets and notes that firm proof that aiming for healing improves long-term outcomes was still emerging.

Topics Monitoring Research

Jargon explained treat to target mucosal healing biomarker STRIDE

Magnetic Resonance Enterography and Intestinal Ultrasound for the Assessment and Monitoring of Crohn's Disease

Journal of Crohn's and Colitis via PubMed Central Systematic review Sep 2024 For professionals

A review of how MRI enterography and bowel ultrasound are now the main non-invasive ways to diagnose and monitor Crohn's. It describes what active Crohn's looks like on each scan, how they fit into the diagnostic pathway and track response to treatment, and areas still debated, plus newer developments such as AI.

Topics Diagnosis and tests Monitoring

Jargon explained MRI enterography intestinal ultrasound contrast

Intestinal ultrasound and management of small bowel Crohn's disease

Therapeutic Advances in Gastroenterology via PubMed Central Systematic review 2018 For professionals

A review explaining why bowel ultrasound suits small bowel Crohn's: it is non-invasive, quick to arrange and inexpensive. It reports that ultrasound can accurately find small bowel Crohn's and complications such as narrowings, fistulas and abscesses, and can follow people after surgery or on treatment.

Topics Diagnosis and tests Monitoring Complications

Jargon explained intestinal ultrasound stricture fistula abscess small bowel

Studys 4

Development and validation of a rapid, generic measure of disease control from the patient's perspective: the IBD-Control questionnaire

Gut (BMJ) via PubMed Central Study Jul 2014 For professionals

UK researchers built a short questionnaire, with input from patients, that asks people with IBD how well controlled their condition has felt over the past two weeks. It has 13 yes/no/not sure questions plus a 0-100 scale and took about a minute to complete. In nearly 300 patients it gave consistent results and tracked well with doctors' own activity scores.

Topics Monitoring Flare-ups

Jargon explained patient reported outcome measure visual analogue scale validation

Fecal calprotectin as an inflammatory biomarker in small bowel Crohn disease

Porto Biomedical Journal via PubMed Central Study Jul 2024 For professionals

A study of 196 people with Crohn's affecting only the small bowel, comparing calprotectin levels with capsule endoscopy findings. Calprotectin matched the camera findings only moderately and no cut-off was reliable enough on its own, supporting the point that a normal calprotectin does not rule out small bowel inflammation.

Topics Diagnosis and tests Monitoring

Jargon explained faecal calprotectin capsule endoscopy small bowel

Diagnostic accuracy of magnetic resonance enterography and small bowel ultrasound for the extent and activity of newly diagnosed and relapsed Crohn's disease (METRIC): a multicentre trial

The Lancet Gastroenterology & Hepatology via PubMed Central Study Jun 2018 For professionals

A UK trial at eight NHS hospitals comparing MRI enterography with bowel ultrasound in 284 people with new or relapsing Crohn's. Both were very good at spotting small bowel Crohn's and were judged valid first tests and alternatives to colonoscopy of the ileum, but MRI was more accurate at mapping how much bowel was affected. The authors concluded MRI is generally preferred in the NHS where available.

Topics Diagnosis and tests Monitoring Research

Jargon explained MRI enterography intestinal ultrasound small bowel sensitivity

Crohn's disease management after intestinal resection: a randomised trial (POCER)

The Lancet Study Feb 2015 For professionals

A trial of how to stop Crohn's returning after bowel surgery. Treating people according to their risk, checking with a colonoscopy at six months and stepping up treatment if the disease had come back worked better than standard drug treatment alone. It also showed that even low-risk patients need monitoring.

Topics Surgery Monitoring Research

Jargon explained post-operative recurrence colonoscopy step-up resection

Guides 1

Guideline review: 2025 British Society of Gastroenterology guidelines on inflammatory bowel disease in adults - Part 1: Crohn's disease

Frontline Gastroenterology (via PMC) Guide Nov 2025 For professionals

A readable summary of what the 2025 BSG guideline says about Crohn's. Key points: early 'top-down' infliximab with an immunomodulator for moderate to severe disease; avoiding long or repeated steroid courses; no longer suggesting immunomodulators alone; upadacitinib and risankizumab added; vedolizumab no longer routinely suggested; drug-level testing for anti-TNFs; early surgery as an option for limited ileocaecal disease; and offering early treatment after resection.

Topics Medicines Surgery Monitoring

Jargon explained top-down step-up therapeutic drug monitoring ileocaecal resection Rutgeerts score immunogenicity

Web pages 1

Tools 2